Anti-platelet effects of epigallocatechin-3-gallate in addition to the concomitant aspirin, clopidogrel or ticagrelor treatment
Open Access
- 1 May 2018
- journal article
- research article
- Published by Korean Association of Internal Medicine in The Korean Journal of Internal Medicine
- Vol. 33 (3), 522-531
- https://doi.org/10.3904/kjim.2016.228
Abstract
Background/Aims: Although epigallocatechin-3-gallate (EGCG), which is found in high contents in the dried leaves of green tea, has been reported to have an anti-platelet effect, synergistic effects of EGCG in addition to current anti-platelet medications remains to be elucidated. Methods: Blood samples were obtained from 40 participants who took aspirin (ASA, n = 10), clopidogrel (CPD, n = 10), ticagrelor (TCG, n = 10) and no anti-platelet medication (Control, n = 10). Ex vivo platelet aggregation and adhesion under various stimulators were analyzed by multiple electrode aggregometry (MEA) and Impact-R systems. PAC-1 and P-selectin expressions in human platelets were analyzed by flow cytometry. Results: In MEA analysis, adenosine diphosphate (ADP) and thrombin receptor activating peptide (TRAP)-induced platelet aggregations were lower in the CPD and the TCG groups; arachidonic acid (AA)-induced platelet aggregation was lower in the ASA group, whereas collagen (COL)-induced platelet aggregations were comparable among four groups. EGCG significantly reduced ADP- and COL-induced platelet aggregation in dose-dependent manner (ADP, p = 0.04; COL, p < 0.01). There were no additional suppressions of platelet aggregation stimulated by AA in the ASA group, and by ADP in the CPD and TCG groups. Moreover, EGCG suppressed shear stress-induced platelet adhesion on Impact-R, and had no effect on P-selectin and PAC-1 expressions. Conclusions: Ex vivo treatment of EGCG inhibited platelet adhesion and aggregation without changes in P-selectin and PAC-1 expression. There was no additional suppressions in platelet aggregation stimulated by AA in the ASA group and ADP in the CPD and TCG groups.Funding Information
- Korea Health Industry Development Institute
- Ministry of Health and Welfare (HI14C0209)
- National Research Foundation of Korea
- Ministry of Science, ICT and Future Planning (2014R1A2A1A11051998)
This publication has 38 references indexed in Scilit:
- Anti‐platelet therapy: ADP receptor antagonistsBritish Journal of Clinical Pharmacology, 2011
- The Human Endogenous Circadian System Causes Greatest Platelet Activation during the Biological Morning Independent of BehaviorsPLOS ONE, 2011
- Flavanols from green tea and phenolic acids from coffee: Critical quantitative evaluation of the pharmacokinetic data in humans after consumption of single doses of beveragesMolecular Nutrition & Food Research, 2011
- Signaling During Platelet Adhesion and ActivationArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function testsThrombosis Research, 2008
- Targeting Receptor Tyrosine Kinases for Chemoprevention by Green Tea Catechin, EGCGInternational Journal of Molecular Sciences, 2008
- Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatmentThrombosis and Haemostasis, 2008
- Aspirin and Clopidogrel Drug Response in Patients Undergoing Percutaneous Coronary Intervention: The Role of Dual Drug ResistanceJournal of Invasive Cardiology, 2006
- Antithrombotic Activities of Green Tea Catechins and (−)-Epigallocatechin GallateThrombosis Research, 1999
- Platelet aggregation inhibitors in hot water extract of green tea.CHEMICAL & PHARMACEUTICAL BULLETIN, 1990